Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
Peters JM, Ansari MQ.
Arch Pathol Lab Med. 2011 Jan;135(1):44-54. doi: 10.5858/2010-0387-RAR.1.
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C.
Br J Haematol. 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x.
Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
Klco JM, Mullighan CG.
Nat Rev Cancer. 2021 Feb;21(2):122-137. doi: 10.1038/s41568-020-00315-z. Epub 2020 Dec 16.
Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders?
Zinngrebe J, Debatin KM, Fischer-Posovszky P.
Leukemia. 2020 Sep;34(9):2305-2316. doi: 10.1038/s41375-020-0886-x. Epub 2020 May 30.
Revumenib: First Approval.
Syed YY.
Drugs. 2025 Apr;85(4):577-583. doi: 10.1007/s40265-025-02161-5.
Cytokines, Signaling and Epigenetic Mechanisms: Shaping the Acute Lymphoblastic Leukemia Microenvironment.
Simioni C, Neri LM.
Cells. 2026 Mar 5;15(5):467. doi: 10.3390/cells15050467.
Chromosomal aberrations and prognostic analysis of secondary acute myeloid leukemia-a retrospective study.
Song M, Zhang T, Yang D, Xiao H, Wang H, Ye Q, Zhai Z.
PeerJ. 2023 May 15;11:e15333. doi: 10.7717/peerj.15333. eCollection 2023.
Evolutionarily conserved signaling pathways: acting in the shadows of acute myelogenous leukemia's genetic diversity.
Heidel FH, Arreba-Tutusaus P, Armstrong SA, Fischer T.
Clin Cancer Res. 2015 Jan 15;21(2):240-8. doi: 10.1158/1078-0432.CCR-14-1436.
[Epidemiology of acute lymphoid leukemia].
Roy P, Coleman MP.
Rev Epidemiol Sante Publique. 1992;40(5):323-34.
[Acute leukemias in humans. I. Definition, etiology, and pathogenesis of acute leukemias. Classification of acute myeloid leukemia].
Lemez P.
Sb Lek. 1989 Nov;91(11-12):368-84.
